78 signals · bluesky, newsapi, News / RSS
Scores are directional signals derived from aggregated public data — not verified findings or investment advice. Methodology
Signal-based estimates from public data — not verified assessments. Learn more
Some stress signals present but below significant thresholds.
Low risk signals — no significant operational or reputational pressure detected.
Auto-generated from public signals — AI summary pending. Based on 3 recent signals.
Jefferies upgrades Tempus AI stock rating to hold, raises price target to $70 Investing.com
Baird maintains Tempus AI at Outperform, raises price target to $92 from $85 TradingView
AI-driven precision medicine platform.
Based on 78 signals across 3 sources · snapshot 4 Nov 2026
Strong: enough recent evidence to trust this score.
Overall community sentiment for Tempus is positive based on public signals as of 4 Nov 2026.
Based on 78 signals across 3 sources
Scores are directional signals derived from public data — not certified assessments or recommendations. Confidence indicates data coverage, not accuracy. Learn how scores are calculated →
Derived from public sources such as news, filings, and reported events.
Do You Own Tempus AI Without Knowing It? Check These ETFs After Its Earnings Surge. The post Do You Own Tempus AI Without Knowing It? Check These ETFs After Its Earnings Surge appeared first on 24/7 Wall St.. Tempus AI (NASDAQ:TEM) was trading higher this afternoon. It sat at $80.31, up 11.21% after the precision medicine company reported th…
Tempus AI (NASDAQ:TEM) was trading higher this afternoon.